An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer
ToLymph Inc.
ToLymph Inc.
AstraZeneca
Shanghai Pulmonary Hospital, Shanghai, China
AstraZeneca
Revolution Medicines, Inc.
Iovance Biotherapeutics, Inc.
Genelux Corporation
Institut Bergonié
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
UCB Pharma
Duke University
Eli Lilly and Company
Mereo BioPharma
MultiVir, Inc.
Guangzhou Medical University
First Hospital of Shijiazhuang City
First Hospital of Shijiazhuang City
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals
H. Lee Moffitt Cancer Center and Research Institute
Eli Lilly and Company
Merck KGaA, Darmstadt, Germany
Duke University
Pfizer
Sanofi
Eli Lilly and Company
Hospital Arnau de Vilanova
Hospital Arnau de Vilanova
Pfizer
National Institutes of Health Clinical Center (CC)
Amgen
Eli Lilly and Company